Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630393 · ClinicalTrials.gov registry record · NA
Ultralow Versus Standard Pneumoperitoneum Pressure
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT03630393: Clinical Trial NA study, sponsored by OhioHealth.
NCT03630393 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03630393, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
The investigators plan to compare insufflation pressures during robotic assisted laparoscopic prostatectomy (RALP). Standard pressure is typically 15 mmHg, while in a previous study the investigators determined that 6 mmHg is possible routinely. Therefore, the investigators plan to compare the clinical outcomes of participants at a pneumoperitoneal pressure of 15 versus 6 mmHg.
Primary Outcome
The cumulative dose (milligrams) of each opioid medication administered was calculated and converted to milligram morphine equivalents (MME) for each participant.
Interventions
- OTHER Pneumoperitoneum Pressure 6 mmHg
- OTHER Pneumoperitoneum Pressure 15 mmHg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2021-02-10 |
| Phase | NA |
Why NCT03630393 stopped before completion
NCT03630393 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Pneumoperitoneum Pressure 6 mmHg is the first listed.
NCT03630393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03630393 about?
NCT03630393 is a clinical study titled "Ultralow Versus Standard Pneumoperitoneum Pressure". The investigators plan to compare insufflation pressures during robotic assisted laparoscopic prostatectomy (RALP). Standard pressure is typically 15 mmHg, while in a previous study the investigators determined that 6 mmHg is possible routinely. Therefore, the investigators plan to compare the clini...
What is the current status of trial NCT03630393?
This trial is currently terminated. It is a NA study. The enrollment target is 170 participants. The study started on 2019-05-09. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT03630393?
The interventions under investigation include: Pneumoperitoneum Pressure 6 mmHg (OTHER), Pneumoperitoneum Pressure 15 mmHg (OTHER).
Who is sponsoring clinical trial NCT03630393?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03630393's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI